Details
Stereochemistry | ACHIRAL |
Molecular Formula | Mg.O2 |
Molecular Weight | 56.3038 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Mg++].[O-][O-]
InChI
InChIKey=SPAGIJMPHSUYSE-UHFFFAOYSA-N
InChI=1S/Mg.O2/c;1-2/q+2;-2
Molecular Formula | Mg |
Molecular Weight | 24.305 |
Charge | 2 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | O2 |
Molecular Weight | 31.9988 |
Charge | -2 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Hydrogen peroxide has been used in medicine for more than 100 years. It is known in surgery as a highly useful irrigation solution by virtue of both its hemostatic and its antimicrobial effects. Hydrogen peroxide is a mild antiseptic used on the skin to prevent infection of minor cuts, scrapes, and burns. It may also be used as a mouth rinse to help remove mucus or to relieve minor mouth irritation (e.g., due to canker/cold sores, gingivitis). This product works by releasing oxygen when it is applied to the affected area. The release of oxygen causes foaming, which helps to remove dead skin and clean the area. Hydrogen peroxide is a strong oxidizing agent used in aqueous solution as a ripening agent, bleach, and topical anti-infective. It is relatively unstable and solutions deteriorate over time unless stabilized by the addition of acetanilide or similar organic materials.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0016491 Sources: http://adisinsight.springer.com/drugs/800039206 |
|||
Target ID: O94759 Gene ID: 7226.0 Gene Symbol: TRPM2 Target Organism: Homo sapiens (Human) |
4.54 null [pEC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | ESKATA Approved UseESKATA is indicated for the treatment of seborrheic keratoses that are raised. Launch Date2017 |
|||
Preventing | Hydrogen Peroxide Solution Approved UseUses of Hydrogen Peroxide Solution:
It is used to prevent skin infections.
It is used to help get rid of phlegm or mucus or help with a sore mouth. |
|||
Primary | Hydrogen Peroxide Solution Approved UseHydrogen peroxide is a mild antiseptic used on the skin to prevent infection of minor cuts, scrapes, and burns. It may also be used as a mouth rinse to help remove mucus or to relieve minor mouth irritation (e.g., due to canker/cold sores, gingivitis). Launch Date1982 |
PubMed
Title | Date | PubMed |
---|---|---|
Activation of JNK, p38 and ERK mitogen-activated protein kinases by chromium(VI) is mediated through oxidative stress but does not affect cytotoxicity. | 2000 Aug |
|
Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. | 2000 Feb 18 |
|
Characterization of two mu class glutathione S-transferases from guinea pig lens. | 2000 Jan |
|
Cynandione A from Cynanchum wilfordii protects cultured cortical neurons from toxicity induced by H2O2, L-glutamate, and kainate. | 2000 Jan 15 |
|
Class A scavenger receptor up-regulation in smooth muscle cells by oxidized low density lipoprotein. Enhancement by calcium flux and concurrent cyclooxygenase-2 up-regulation. | 2000 Jun 9 |
|
Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress. | 2000 Mar |
|
Involvement of lipoxygenase in lysophosphatidic acid-stimulated hydrogen peroxide release in human HaCaT keratinocytes. | 2000 Mar 15 |
|
Neurons and astrocytes express EPO mRNA: oxygen-sensing mechanisms that involve the redox-state of the brain. | 2000 May |
|
Redox state dependency of HERGS631C channel pharmacology: relation to C-type inactivation. | 2000 May 26 |
|
Simultaneous measurement of ERK, p38, and JNK MAP kinase cascades in vascular smooth muscle cells. | 2000 Sep-Oct |
|
Repression of GADD153/CHOP by NF-kappaB: a possible cellular defense against endoplasmic reticulum stress-induced cell death. | 2001 Apr 19 |
|
Manganese superoxide dismutase signals matrix metalloproteinase expression via H2O2-dependent ERK1/2 activation. | 2001 Apr 27 |
|
Reactive carbonyl formation by oxidative and non-oxidative pathways. | 2001 Aug 1 |
|
Thioredoxin peroxidase-1 (peroxiredoxin-1) is increased in thioredoxin-1 transfected cells and results in enhanced protection against apoptosis caused by hydrogen peroxide but not by other agents including dexamethasone, etoposide, and doxorubicin. | 2001 Aug 1 |
|
Transcriptional induction of MKP-1 in response to stress is associated with histone H3 phosphorylation-acetylation. | 2001 Dec |
|
Induction of vascular endothelial growth factor expression and hypoxia-inducible factor 1alpha protein by the oxidative stressor arsenite. | 2001 Dec 21 |
|
Dopaminergic cell death induced by MPP(+), oxidant and specific neurotoxicants shares the common molecular mechanism. | 2001 Feb |
|
Increased 15-HPETE production decreases prostacyclin synthase activity during oxidant stress in aortic endothelial cells. | 2001 Feb 1 |
|
Hyperoxia inhibits oxidant-induced apoptosis in lung epithelial cells. | 2001 Jan 5 |
|
Characterization of a stellate cell activation-associated protein (STAP) with peroxidase activity found in rat hepatic stellate cells. | 2001 Jul 6 |
|
Cytokine mRNA profiles in cultured human skin component cells exposed to various chemicals: a simulation model of epicutaneous stimuli induced by skin barrier perturbation in comparison with that due to exposure to haptens or irritant. | 2001 Jun |
|
Repression of phenobarbital-dependent CYP2B1 mRNA induction by reactive oxygen species in primary rat hepatocyte cultures. | 2001 Jun |
|
Activation of NFkappaB and MnSOD gene expression by free radical scavengers in human microvascular endothelial cells. | 2001 Jun 15 |
|
Human alveolar macrophages and granulocyte-macrophage colony-stimulating factor-induced monocyte-derived macrophages are resistant to H2O2 via their high basal and inducible levels of catalase activity. | 2001 Jun 29 |
|
IL-4 gene expression up-regulated by mercury in rat mast cells: a role of oxidant stress in IL-4 transcription. | 2001 Mar |
|
Variants of peroxiredoxins expression in response to hydroperoxide stress. | 2001 Mar 15 |
|
Proteasome inhibition in oxidative stress neurotoxicity: implications for heat shock proteins. | 2001 May |
|
The influence of oxidative stress on catalase and MnSOD gene transcription in astrocytes. | 2001 May 4 |
|
Acetaminophen induces apoptosis of C6 glioma cells by activating the c-Jun NH(2)-terminal protein kinase-related cell death pathway. | 2001 Oct |
|
Poly(ADP-ribose) glycohydrolase mediates oxidative and excitotoxic neuronal death. | 2001 Oct 9 |
|
High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells. | 2002 Aug |
|
Copper uptake is required for pyrrolidine dithiocarbamate-mediated oxidation and protein level increase of p53 in cells. | 2002 Aug 1 |
|
An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage. | 2002 Aug 15 |
|
Expression of caveolin-1 induces premature cellular senescence in primary cultures of murine fibroblasts. | 2002 Jul |
|
Superoxide anion-dependent Raf/MEK/ERK activation by peroxisome proliferator activated receptor gamma agonists 15-deoxy-delta(12,14)-prostaglandin J(2), ciglitazone, and GW1929. | 2002 Jul 15 |
|
D-penicillamine cooperates with copper sulfate to enhance the surface expression of functional Fas antigen in rheumatoid synovial fibroblasts via the generation of hydrogen peroxide. | 2002 Jul-Aug |
|
Menadione biphasically controls JNK-linked cell death in leukemia Jurkat T cells. | 2002 Jun |
|
Cellular stresses profoundly inhibit protein synthesis and modulate the states of phosphorylation of multiple translation factors. | 2002 Jun |
|
Overexpression of human metallothionein-III prevents hydrogen peroxide-induced oxidative stress in human fibroblasts. | 2002 Jun 19 |
|
Reversible inactivation of the tumor suppressor PTEN by H2O2. | 2002 Jun 7 |
|
Signals of oxidant-induced cardiomyocyte hypertrophy: key activation of p70 S6 kinase-1 and phosphoinositide 3-kinase. | 2002 Mar |
|
Protein overload-induced NF-kappaB activation in proximal tubular cells requires H(2)O(2) through a PKC-dependent pathway. | 2002 May |
|
Doxorubicin-induced apoptosis: implications in cardiotoxicity. | 2002 May-Jun |
|
Mechanisms of the genotoxicity of crocidolite asbestos in mammalian cells: implication from mutation patterns induced by reactive oxygen species. | 2002 Oct |
|
Reactive oxygen species stimulated human hepatoma cell proliferation via cross-talk between PI3-K/PKB and JNK signaling pathways. | 2002 Oct 15 |
|
Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2). | 2002 Oct 25 |
|
Is calcineurin a peroxide-specific sensor in T-lymphocytes? | 2002 Sep |
|
Iron augments stage-I and stage-II tumor promotion in murine skin. | 2002 Sep 26 |
|
Molecular inhibitory mechanisms of antioxidant enzymes in rat liver and kidney by cadmium. | 2002 Sep 30 |
|
The antioxidant cocktail effective microorganism X (EM-X) inhibits oxidant-induced interleukin-8 release and the peroxidation of phospholipids in vitro. | 2002 Sep 6 |
Sample Use Guides
Topical solution: 40% (w/w) hydrogen peroxide. Apply 4 times, approximately 1 minute apart, to the
targeted lesion(s) during a single in-office treatment
session.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23537657
Hydrogen peroxide (H2O2, 100-500 uM) caused a concentration-dependent decrease in the activity of recombinant mouse 3-MST enzyme. In mitochondria isolated from murine hepatoma cells, H2O2 (50-500 uM) caused a concentration-dependent decrease in production of H2S from 3-MP. In cultured murine hepatoma cells H2O2, (3-100 uM), did not result in overall cytotoxicity, but caused a partial decrease in basal oxygen consumption and respiratory reserve rapacity. The positive bioenergetic effect of 3-MP (100-300 nM) was completely abolished by pre-treatment of the cells with H2O2 (50 uM).
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 05:09:15 GMT 2023
by
admin
on
Sat Dec 16 05:09:15 GMT 2023
|
Record UNII |
X8YVJ0TN96
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QA02AA03
Created by
admin on Sat Dec 16 05:09:15 GMT 2023 , Edited by admin on Sat Dec 16 05:09:15 GMT 2023
|
||
|
WHO-VATC |
QA06AD03
Created by
admin on Sat Dec 16 05:09:15 GMT 2023 , Edited by admin on Sat Dec 16 05:09:15 GMT 2023
|
||
|
WHO-ATC |
A02AA03
Created by
admin on Sat Dec 16 05:09:15 GMT 2023 , Edited by admin on Sat Dec 16 05:09:15 GMT 2023
|
||
|
WHO-ATC |
A06AD03
Created by
admin on Sat Dec 16 05:09:15 GMT 2023 , Edited by admin on Sat Dec 16 05:09:15 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB14439MIG
Created by
admin on Sat Dec 16 05:09:15 GMT 2023 , Edited by admin on Sat Dec 16 05:09:15 GMT 2023
|
PRIMARY | |||
|
DB13486
Created by
admin on Sat Dec 16 05:09:15 GMT 2023 , Edited by admin on Sat Dec 16 05:09:15 GMT 2023
|
PRIMARY | |||
|
1666106
Created by
admin on Sat Dec 16 05:09:15 GMT 2023 , Edited by admin on Sat Dec 16 05:09:15 GMT 2023
|
PRIMARY | RxNorm | ||
|
100000076807
Created by
admin on Sat Dec 16 05:09:15 GMT 2023 , Edited by admin on Sat Dec 16 05:09:15 GMT 2023
|
PRIMARY | |||
|
X8YVJ0TN96
Created by
admin on Sat Dec 16 05:09:15 GMT 2023 , Edited by admin on Sat Dec 16 05:09:15 GMT 2023
|
PRIMARY | |||
|
238-438-1
Created by
admin on Sat Dec 16 05:09:15 GMT 2023 , Edited by admin on Sat Dec 16 05:09:15 GMT 2023
|
PRIMARY | |||
|
C517394
Created by
admin on Sat Dec 16 05:09:15 GMT 2023 , Edited by admin on Sat Dec 16 05:09:15 GMT 2023
|
PRIMARY | |||
|
m7014
Created by
admin on Sat Dec 16 05:09:15 GMT 2023 , Edited by admin on Sat Dec 16 05:09:15 GMT 2023
|
PRIMARY | Merck Index | ||
|
14452-57-4
Created by
admin on Sat Dec 16 05:09:15 GMT 2023 , Edited by admin on Sat Dec 16 05:09:15 GMT 2023
|
PRIMARY | |||
|
MAGNESIUM PEROXIDE
Created by
admin on Sat Dec 16 05:09:15 GMT 2023 , Edited by admin on Sat Dec 16 05:09:15 GMT 2023
|
PRIMARY | |||
|
X8YVJ0TN96
Created by
admin on Sat Dec 16 05:09:15 GMT 2023 , Edited by admin on Sat Dec 16 05:09:15 GMT 2023
|
PRIMARY | |||
|
7986
Created by
admin on Sat Dec 16 05:09:15 GMT 2023 , Edited by admin on Sat Dec 16 05:09:15 GMT 2023
|
PRIMARY | |||
|
1312-95-4
Created by
admin on Sat Dec 16 05:09:15 GMT 2023 , Edited by admin on Sat Dec 16 05:09:15 GMT 2023
|
SUPERSEDED | |||
|
4595
Created by
admin on Sat Dec 16 05:09:15 GMT 2023 , Edited by admin on Sat Dec 16 05:09:15 GMT 2023
|
PRIMARY | |||
|
61745
Created by
admin on Sat Dec 16 05:09:15 GMT 2023 , Edited by admin on Sat Dec 16 05:09:15 GMT 2023
|
PRIMARY | |||
|
DTXSID9049667
Created by
admin on Sat Dec 16 05:09:15 GMT 2023 , Edited by admin on Sat Dec 16 05:09:15 GMT 2023
|
PRIMARY | |||
|
CHEMBL3707298
Created by
admin on Sat Dec 16 05:09:15 GMT 2023 , Edited by admin on Sat Dec 16 05:09:15 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |